品牌分类
品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com
商品描述
Related Products
- MS436
- Barasertib (AZD1152-HQPA)
- Lomeguatrib
- EPZ004777
- Ruxolitinib (INCB018424)
- Decitabine (NSC127716, 5AZA-CdR)
Molarity CalculatorDilution Calculator
| DiscoveryProbe™ Chromatin/Epigenetics-related Compounds Panel |
Sample solution is provided at 25 µL, 10mM.
Click and Customize the Panelwith your own choices of compounds/size/quantities/chemical forms etc.
Nature.2017 Jan 19;541(7637):417-420.
Nature.2018 Nov;563(7731):407-411.
Nature.2018 Jun 13.
Nature.2018 Jun 27.
Nature.2018 Mar 29;555(7698):673-677.
Nature.2017 Sep 7;549(7670):96-100.
Nature.2016 Apr 21;532(7599):398-401.
Science.2016 Aug 5;353(6299)594-8
Nat Nanotechnol.2017 Dec;12(12):1190-1198.
Nature Biotechnology.2017 Jun;35(6):569-576
Nat Med.2018 Sep 17.
Cell.2018 Dec 21. pii: S0092-8674(18)31561-7.
Cell.Available online 25 October 2018.
Cell.2018 Sep 27. pii: S0092-8674(18)31183-8.
Cell.2018 Jun 28;174(1):172-186.e21.
Cell.2018 Feb 22;172(5):1007-1021.e17.
Cell.2017 Nov 30;171(6):1284-1300.e21.
Cell.2017 Aug 17. pii: S0092-8674(17)30869-3.
Cell.2017 Jul 13;170(2):312-323
Nat Med.2018 Jan 29.
Nat Med.2017 Nov;23(11):1342-1351.
Cell.2017 Apr 6;169(2):286-300.
Cell.2015 Aug 27;162(5):987-1002.
Cell.2015 Feb 12;160(4):729-44.
Nature Medicine.2017 Apr;23(4):493-500.
Cancer Cell.2018 May 14;33(5):905-921.e5.
Cancer Cell.2018 Apr 9;33(4):752-769.e8.
Cancer Cell.2018 Mar 12;33(3):401-416.e8.
Cancer Cell.2017 Aug 14;32(2):253-267.e5.
Nat Methods.2018 Jul;15(7):523-526.
Cell Stem Cell.2018 May 3;22(5):769-778.e4.
Cell Stem Cell.2017 Nov 20. pii: S1934-5909(17)30375-2.
| Catalog No. | Product Name | Summary | Targets | CAS Number | Smiles | |
| A4112 | Barasertib (AZD1152-HQPA) | Aurora Kinase B inhibitor, Potent and selective | Chromatin/Epigenetics|Aurora Kinase | 722544-51-6 | CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCO | |
| B1012 | MS436 | BRD4 inhibitor | Chromatin/Epigenetics|Bromodomain | 1395084-25-9 | CC1=CC(=NNC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3)C(=CC1=O)N | |
| A1906 | Decitabine (NSC127716, 5AZA-CdR) | Deoxycytidine analog and cellular diifferentiation inducer | Chromatin/Epigenetics|DNA Methyltransferase | 2353-33-5 | C1C(C(OC1N2C=NC(=NC2=O)N)CO)O | |
| A1912 | Lomeguatrib | MGMT inhibitor | Chromatin/Epigenetics|DNA Methyltransferase | 192441-08-0 | C1=C(SC=C1Br)COC2=NC(=NC3=C2NC=N3)N | |
| A4170 | EPZ004777 | DOT1L inhibitor | Chromatin/Epigenetics|Histone Methyltransferase | 1338466-77-5 | CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=CC4=C3N=CN=C4N)O)O | |
| A3012 | Ruxolitinib (INCB018424) | Poten JAK1/2 inhibitor | Chromatin/Epigenetics|JAK | 941678-49-5 | C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 | |
| A4154 | Olaparib (AZD2281, Ku-0059436) | Potent PARP1/PARP2 inhibitor | Chromatin/Epigenetics|PARP | 763113-22-0 | C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F | |
| A3962 | AZD1208 | PIM kinase inhibitor | Chromatin/Epigenetics|Pim | 1204144-28-4 | C1CC(CN(C1)C2=C(C=CC=C2C=C3C(=O)NC(=O)S3)C4=CC=CC=C4)N | |
| Download the Chromatin/Epigenetics-related Compounds Panel - XLSXDownload the Chromatin/Epigenetics-related Compounds Panel - SDF | ||||||
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
" to show IC50
- Available in stock with overnight delivery and free shipping over $500
- Cost-effective and competitive price to save your findings
- Potent, selective and cell-permeable in inhibiting or activating target molecules
- Diverse in chemical structure and route of administration (oral/i.m/i.v injection etc.)
- Detailed files describing potency, selectivity and applications etc.
- Supported by published data from top peer-reviewed journals
- Guaranteed high quality with NMR and HPLC validation
| Solubility | Soluble in DMSO | Storage | Desiccate at -20°C |
| Packaging | 96 well plate | Form | Powder |
| General tips | For obtaining a higher solubility , please warm the tube at 37°C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months. | ||
| Shipping Condition | Evaluation sample solution : ship with blue iceAll other available size:ship with RT , or blue ice upon request | ||
A wide range of well-characterized bioactive molecules that covers various targets related to chromatin/epigenetics, including bromodomain, aurora kinase, JAK, PARP and Pim etc. Facilitate your research towards the insights of histone modification, gene expression regulation, genetic disorders and cancer etc. Applicable in cellular assays, animal models and drug screenings etc.
1. Chen ZX, Riggs AD. DNA methylation and demethylation in mammals. J Biol Chem. 2011 May 27;286(21):18347-53.Abstract Understanding how these patterns of 5-methylcytosine are established and maintained requires the elucidation of mechanisms for both DNA methylation and demethylation. Important remaining challenges are to understand how DNA methylation systems function in vivo and in the context of chromatin. In addition, the enzymes and mechanisms for demethylation remain to be elucidated, recent studies implicate base excision repair for genome-wide DNA demethylation in germ cells and early embryos.
2. Korb E, Herre M, Zucker-Scharff I, Darnell RB, Allis CD. BET protein Brd4activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice.Nat Neurosci. 2015 Oct;18(10):1464-73.Abstract Brd4 is a member of the BET protein family, which binds acetylated histones and has a critical role in numerous cell types in regulating transcription. JQ1, a small molecule BET inhibitor, yet almost nothing is known about Brd4 function in the brain. Here we show that Brd4 is a key player in neuronal function and mediates the transcriptional regulation underlying learning and memory. The loss of Brd4 function affects critical synaptic proteins. Brd4 provides a critical link between neuronal activation and the transcriptional responses that occur during memory formation.
